May 13, 2026

AI Discharge Summaries Show Low Harm Risk

Most reviewed summaries were rated as posing no harm risk, although omissions remained common.

Conexiant

May 13, 2026

AOPT Plus Collagen May Ease Rosacea

Randomized trial suggests better short-term outcomes and lower recurrence at 24 weeks

Conexiant

May 13, 2026

Medical Oddities: Ancient Practice Calms Modern BP

Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.

Conexiant

May 08, 2026

Amputation Rates Rose in Opioid-Related Hospitalizations

National inpatient analysis found steeper increases in amputations during opioid-related hospitalizations, particularly in the Northeast and West.

Conexiant

May 07, 2026

Optimizing Nodal Staging for Early Metastasis Detection in cSCC

Ultrasonography, CT may be superior, but have limited benefit in patients who are immunosuppressed. 

Conexiant

May 07, 2026

Tirzepatide's Surprising Skin Side Effect

A single case report described possible lichen planus pigmentosus inversus following tirzepatide initiation.

Conexiant

May 05, 2026

Medical Oddities: Brain Health, Sunny-Side Up

Breakfast, bacteria, and brain wiring—small things show big implications this week.

Conexiant

May 05, 2026

Smartwatch May Track AD Status in Children

Wearable-derived scratching measures align with disease activity and short-term treatment response in pediatric patients with atopic dermatitis.

Conexiant

May 05, 2026

GLP-1 Agents May Reduce Psoriasis Severity

National Psoriasis Foundation review highlights limited evidence and potential metabolic links

Conexiant

May 05, 2026

Second Primary Cancer Risk Shifts Over Time

US registry study finds overall declines but rising risk in lung, melanoma, and older survivor groups

Conexiant